Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Routine Blood Tests Could Help Predict Fitness Changes

By LabMedica International staff writers
Posted on 29 May 2017
In an initial study of marathoners (runners-bikers) aged >60 years, researchers have found that results from a combination of routine blood analytes predicted improvement or decrease in their fitness.

Beneficial impact of endurance sports on physical and mental performance can be seen in blood test results. In collaboration with the Health and Prevention Center of the Healthcare Institution for City of Vienna employees, a group of researchers from the biobank at Medical University (MedUni) of Vienna has shown, in a study conducted with older marathoners, that specific blood parameters could be used in the opposite way to predict future changes in fitness. This could be used for personalized sports medicine to optimize endurance-training programs for individuals.

Within the Austrian research infrastructure BBMRI.at, MedUni Vienna biobank works closely with the biobanks and medical archives of the other Austrian universities. The consortium has set itself the joint goal of improving the quality of biomaterial used in biomedical studies and hence increasing the reliability of research results nationwide.

In the APSOEM Marathon Study, which has been running since 2009, MedUni Vienna's biobank has already demonstrated that the cognitive ability and mental state of older marathon runners aged >60 are significantly better than those of comparable age groups who do not engage in any endurance sport. Data gathered in this study were used in the new study.

The follow-up study was conducted by a research group headed by Dr. Helmuth Haslacher from MedUni Vienna, in collaboration with Robert Winker's team from the Health and Prevention Center of the Healthcare Institution for City of Vienna employees. They took blood samples from 47 marathoners before an ergometer test, and carried out lab tests to determine levels of analytes, including inflammatory markers, and muscle and liver parameters. Ergometer tests were repeated after an interval of 3 years: approximately 2/3 of the athletes showed a decline in fitness since the initial test. The researchers found that it was possible to use the earlier blood results as a basis for predicting who had lost fitness by the time of the follow-up examination, whose fitness level had remained the same, and whose had even improved.

The next step will be to investigate larger groups and other types of sport. A possible future application would be to develop an app for checking fitness.

They study, by Haslacher H et al, was published May 5, 2017, in the journal PLOS One.


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Troponin I Test
Quidel Triage Troponin I Test
New
Biological Indicator Vials
BI-O.K.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.